Prognostic Impact of Lymphocyte–C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.

MLA

Yugawa, Kyohei, et al. “Prognostic Impact of Lymphocyte–C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.” Journal of Gastrointestinal Surgery, vol. 26, no. 1, Jan. 2022, pp. 104–12. EBSCOhost, https://doi.org/10.1007/s11605-021-05085-z.

APA

Yugawa, K., Maeda, T., Kinjo, N., Kawata, K., Ikeda, S., Edahiro, K., Edagawa, M., Omine, T., Kometani, T., Yamaguchi, S., Konishi, K., Tsutsui, S., & Matsuda, H. (2022). Prognostic Impact of Lymphocyte–C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery, 26(1), 104–112. https://doi.org/10.1007/s11605-021-05085-z

Chicago

Yugawa, Kyohei, Takashi Maeda, Nao Kinjo, Koto Kawata, Shinichiro Ikeda, Keitaro Edahiro, Makoto Edagawa, et al. 2022. “Prognostic Impact of Lymphocyte–C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.” Journal of Gastrointestinal Surgery 26 (1): 104–12. doi:10.1007/s11605-021-05085-z.